People: Flamel Technologies S.A. (FLML.O)

FLML.O on Consolidated Issue listed on NASDAQ Global Market

7.94USD
9 Feb 2010
Price Change (% chg)

$0.26 (+3.45%)
Prev Close
$7.94
Open
--
Day's High
$7.94
Day's Low
$7.53
Volume
10,394
Avg. Vol
26,485
52-wk High
$9.94
52-wk Low
$4.10

view people for:

Summary

Name Age Since Current Position
Vannier, Elie 60 2005 Non-Executive Chairman of the Board
Willard, Stephen 48 2005 Chief Executive Officer, Director
Crouzet, Sian 2008 Principal Financial Officer
Jorda, Rafael Chief Operating Officer, Executive Vice President
Portella, Raphaelle 2006 French Legal in-house Counsel
Capelle, Martine 2006 Human Resources Director
Mosseri-Marlio, Charles Director - Strategic Planning and Investor Relations
Meyrueix, Remi 2008 Director - Physico-Chemistry
Kravtzoff, Roger 2008 Pharmaceutical Development Director
Chan, You-Ping Chemistry Department Director
Kalita, Christian 2005 Chief Pharmacis and Director - Quality Assurance and Regulatory Affairs
Castan, Catherine Director - R&D Micropump
Weber, David Supply Chain Director
Bourboulou, Yves Technical Director and Pessac Plant Director
Vick, Jeffery 45 2009 Chief Business Officer
McWilliam, Nigel Director - Business Development
Lemoine, Frederic 2005 Director
Vogelstein, John 73 2005 Director
De Vink, Lodewijk 64 2006 Director
Fildes, Frank 2008 Director
» Insider Trading

Biographies

Name Description
Vannier, Elie Mr. Elie Vannier is Non-Executive Chairman of the Board of Directors of Flamel Technologies S.A., Group Managing Director of WALLY and former Chief Operating Officer of GrandVision SA, Director of Ingénico, Famar, Conbipel and Compagnie Generale de Téléphonie.
Willard, Stephen Mr. Stephen H. Willard is Chief Executive Officer and also serves on the Board of Directors of Flamel Technologies S.A. Prior to being asked to serve in his present capacity by the Board of Directors in June of 2005, Mr. Willard was Flamel’s Chief Financial Officer and General Counsel. Immediately prior to joining the Company in August, 2000, Mr. Willard was employed as a vice president of Biovail, a pharmaceutical company. He also worked as an investment banker at Credit Suisse First Boston and as an attorney with Gibson, Dunn & Crutcher LLP and Shearman & Sterling LLP. He is a graduate of Yale Law School (1985) and Williams College (1982). He is a Director of E-Trade Financial Corporation.
Crouzet, Sian Ms. Siân Crouzet was nominated as Principal Financial Officer of Flamel Technologies S.A. on March 3, 2008. Mrs. Crouzet previously worked as Financial Controller France for McCormick & Company Inc. She also worked five years as an external auditor with Ernst and Young. She is a UK Chartered Accountant and a graduate of Bradford University.
Jorda, Rafael Mr. Rafael Jorda is Chief Operating Officer and Executive Vice President of Flamel Technologies S.A. Mr. Jorda joined the Company in 1991 and specializes in chemical engineering and in the structure-property relationships of materials. From 1986 to 1990, he worked as a research and development scientist on controlled-released and biopolymers at Rhone-Poulenc.
Portella, Raphaelle Ms. Raphaelle Portella is French Legal in-house Counsel of Flamel Technologies S.A. and joined the Company in April 2006. Mrs. Portella previously worked as Head of the Corporate and Business Law Department for ADIA (Adecco Group) for almost 10 years. She graduated from Lyon University with a Master (DESS) in Business Law.
Capelle, Martine Ms. Martine Capelle is Human Resources Director of Flamel Technologies S.A. and joined the Company in 2006. She previously worked for the Danone group for 15 years in different Human Resource functions and roles and prior to that she worked as Human Relations manager for two automobile plants. She is a graduate of Lyon Human Sciences University.
Mosseri-Marlio, Charles Mr. Charles Mosseri-Marlio is Director of Strategic Planning and Investor Relations of Flamel Technologies S.A., having previously served as Associate General Counsel. Mr. Mosseri-Marlio joined the Company in 2004 after working as a portfolio manager of Baldwin Brothers, Inc, a U.S. Investment Advisory firm. Mr. Mosseri-Marlio received his Juris Doctor in 1994 from the University of Colorado.
Meyrueix, Remi Mr. Remi Meyrueix is Director of Physico-Chemistry of Flamel Technologies S.A. Mr. Meyrueix holds the degree of engineer in physics and a doctoral thesis in physics, which he received from the Polytechnic Institute of Grenoble in 1977 and 1980, respectively. He worked at Rhone Poulenc from 1982 to 1990 and joined the Company in early 1991 as a research engineer. He is now managing the Nanotechnology platform in Venissieux, France.
Kravtzoff, Roger Mr. Roger Kravtzoff is Pharmaceutical Development Director of Flamel Technologies S.A. Mr. Kravtzoff received his Doctorat-es Sciences in Biochemistry from Tours University (France ) in 1988 and has a broad expertise in drug delivery system. In 1985, he joined Centre Regional de Transfusion Sanguine as a research engineer, and in 1991, he became a scientist associate director in a subsidiary of the French National Blood Center, Novacell. He joined Biovector Therapeutics in 1993 and worked as a Project Director. He joined the Company in June 2002 and is currently managing the Company's pre-clinical and clinical development regulatory affairs.
Chan, You-Ping Mr. You-Ping Chan is Chemistry Department Director of Flamel Technologies S.A. Mr. Chan received his Doctorate in Philosophy in Chemistry from Université Louis Pasteur, Strasbourg in 1990. After spending a year as a post-doctoral associate at the Massachusetts Institute of Technology, he joined the Company in 1992 as a researcher in polymer science. He currently manages research and development in the field of biocompatible polymers for drug delivery and heads the analytical research group.
Kalita, Christian Mr. Christian Kalita is Chief Pharmacist and Director of Quality Assurance and Regulatory Affairs of Flamel Technologies S.A. Mr. Kalita worked previously at Skye Pharma as Director of Quality for Europe. He also worked from 1990 to 2000 for Merck Lipha and Merck generics in different roles as Chief Pharmacist, head of quality control management and Head of Industrial Affairs.
Castan, Catherine Ms. Catherine Castan is Galenic Department Director of Flamel Technologies S.A. Mrs. Castan joined the Company in 1992 after having spent four years at Sanofi Recherche. She is a graduate of Ecole Nationale Supérieure de Chimie de Montpellier and has a PHD in polymer chemistry, applied in drug delivery.
Weber, David Mr. David Weber is Supply Chain Director of Flamel Technologies S.A. He has more than ten years experience in purchasing and operations management at various international companies including Garrett (Honeywell group) and Isringhausen. Before joining the Company he was Vice President and Cofounder of Pertinence Data Intelligence.
Bourboulou, Yves Mr. Yves Bourboulou is Technical Director and Pessac Plant Director of Flamel Technologies S.A. He worked previously as Plant manager at Pharmacia and Fresenius Kabi. He previously held various senior pharmaceutical positions including as Quality assurance Director and Chief Pharmacist. He has more than 20 years experience in pharmaceutical production; quality and development.
Vick, Jeffery Mr. Jeffery S. Vick is Chief Business Officer of Flamel Technologies S.A. Mr. Vick has more than 20 years experience in the business and research side of the biotechnology industry in both Europe and the US. Prior to joining Flamel, Mr. Vick was Chief Executive Officer of Silence Therapeutics. Mr. Vick previously held senior management positions with Centelion SAS, a wholly-owned subsidiary of Aventis, Genset SA, Cytovia, Inc, and DepoTech Corporation and worked with Sanderling Venture Capital for two years. Mr. Vick holds an Masters of Business Administration from Stanford, an Master of Science in Chemistry from the University of California, San Diego, and a Bachelor of Science in Chemistry from the University of Virginia.
McWilliam, Nigel Mr. Nigel McWilliam is Director of Business Development of Flamel Technologies S.A. Mr. McWilliam has a Bachelors degree in Science from the University of Dundee. He spent almost 20 years with Dow Corning Corporation’s Health Care Businesses in commercial positions in Europe and the U.S.. In 1993 he became President of Leiras Inc., the U.S. subsidiary of a Finnish pharmaceutical company (now part of Bayer-Schering, AG).
Lemoine, Frederic Mr. Frederic Lemoine is a Director of Flamel Technologies S.A. He is Chief Executive Officer of Wendel, former Chairman of the Supervisory Board of Areva, former Deputy General Secretary of Economic Affairs to President Jacques Chirac of France, Chairman of the Supervisory Board of Bureau Veritas, Director of Groupama SA, Legrand and Saint Gobain, Censor to the Supervisory Board of Générale de Santé.
Vogelstein, John Mr. John L. Vogelstein is a Director of Flamel Technologies S.A. Mr. Vogelstein, who is Senior Advisor of Warburg Pincus, is former President of Warburg Pincus and current Director of Mattel, Inc.
De Vink, Lodewijk Mr. Lodewijk J. R. De Vink is a Director of Flamel Technologies S.A. He is former President of Schering Plough International, former Chairman and Chief Executive Officer of Warner Lambert, Inc., Director of Alcon, Roche, and member of the International Advisory Board of Sotheby’s and Member of the European Advisory Council of Rothschild.
Fildes, Frank Dr. Frank J. Fildes, Ph.D. is a Director of Flamel Technologies S.A. Dr. Fildes is former Senior Vice President: Head of Global Development for AstraZeneca, PLC, Director of ProStrakan Group PLC and Fildes Partners Ltd, and a Fellow of the Royal Society of Medicine and the Royal Society of Chemistry. Dr. Fildes is a Fellow of the Royal Society of Medicine and the Royal Society of Chemistry.

Insider Trading

» Full list on Insider Trading
view people for: